The use of vitamin C in seasickness and visually induced motion sickness - a randomised placebo-controlled trial in sailors

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00031323

Enrollment

150

Registered

2023-02-27

Start date

2021-05-14

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T75.3

Interventions

Group 1: sailors susceptible to seasickness, 1250 mg vitamin C chewing gum, 30 minutes of VR exposure Group 2: sailors susceptible to seasickness, placebo chewing gum, 30 minutes of VR exposure Group

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: at least one year of offshore sailing experience written consent to participate in the study

Exclusion criteria

Exclusion criteria: pregnancy balance disorder regular use of simulators or virtual reality goggles

Design outcomes

Primary

Measure	Time frame
Measure of motion sickness symptoms before and after 30 minutes VR exposure with Simulator Sickness Questionnaire (SSQ) and every minute during exposure with Fast Motion Sickness scale (FMS).	—

Countries

France, Germany

Contacts

Public ContactAndreas Koch

Christian-Albrechts-Universität zu Kiel, Institut für experimentelle Medizin, Sektion Maritime Medizin, c/o Schifffahrtsmedizinisches Institut der Marine

a.koch@iem.uni-kiel.de+49 (0)431 54091503

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026